AFL Stock Analysis — Aflac Inc.
Sector: Financials
AI Verdict
Aflac trades at 16.2x next year's earnings despite analysts expecting a 14.8% earnings drop, so you're paying a premium the numbers don't yet support unless its distribution moat delivers a surprise on the bottom line.
Competitive Moat
Aflac dominates the supplemental health and life insurance market in Japan and the US, leveraging long-term distribution partnerships with employers and banks that create high switching costs for policyholders. Its brand recognition and entrenched agent network make it difficult for new entrants to displace its core business.
Summary
Aflac is notable now for its 16.2x forward P/E, which prices in a double-digit earnings decline despite a 19.16% one-year return.
Where It Stands
Aflac's 1-year return of 19.16% and RSI of 62.1 signal neutral-to-elevated momentum, but its 16.2x forward P/E is above the financial sector median of 14x while earnings are expected to fall 14.8%.
Key Metrics
- RSI: 62.1 — Near Overbought
- Trailing P/E: 13.8x
- Forward P/E: 16.2x
- Earnings Growth: -0.1%
- Revenue Growth: +0.1%
- Market Cap: $61.8B
- Dividend Yield: 0.02%
- 1-Year Return: 19.16%
- 52-Week High: $122.80
- 52-Week Low: $96.95
Analyst Consensus
3 Buy · 12 Hold · 8 Sell (23 analysts)
Bull Case
The trailing P/E of 13.8x is below the sector median, suggesting the stock is still valued on last year’s stronger earnings and could benefit if the earnings decline proves less severe.
Bear Case
If the forward P/E of 16.2x compresses to the sector median of 14x due to the projected -14.8% EPS drop, the stock could see a double-digit pullback from current levels.
Catalyst to Watch
Watch for quarterly earnings updates—any sign that EPS declines are less steep than the -14.8% forecast could support the current valuation.